1398108-99-0

Upstream product

• 18162-48-6 tert-butyldimethylsilyl chloride 
• 53293-00-8 hex-5-ynoic acid 
• 1398108-98-9 8-(3-acetylphenyl)-2-amino-9-((2R,4S,5R)-5-((tertbutyldimethylsilyloxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-1H-purin-6(9H)-one 

Downstream Products

• 1398109-00-6 (2R,3S,5R)-5-(8-(3-acetylphenyl)-2-amino-6-oxo-1H-purin-9(6H)-yl)-2-((6-bromohexanoyloxy)methyl)tetrahydrofuran-3-yl hex-5-ynoate 
• 1398109-01-7 ((2R,3S,5R)-5-(8-(3-acetylphenyl)-2-amino-6-oxo-1H-purin-9(6H)-yl)-3-(4-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl)-1H-1,2,3-triazol-4-yl)butanoyloxy)tetrahydrofuran-2-yl)methyl 6-bromohexanoate 
• 1398108-97-8 ((2R,3S,5R)-5-(8-(3-acetylphenyl)-2-amino-6-oxo-1H-purin-9(6H)-yl)-3-(4-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl)-1H-1,2,3-triazol-4-yl)butanoyloxy)tetrahydrofuran-2-yl)methyl 6-(4-((dimethylamino)methyl)-1H-1,2,3-triazol-1-yl)hexanoate 

Relevant academic research and scientific papers

An aquatic host-guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin

We describe the synthesis of a fluorescent deoxyguanosine derivative that co-assembles (in water) with an unlabeled analogue into a heteromeric supramolecular G-quadruplex, which forms a host-guest complex with doxorubicin as evidenced by FRET experiments.